Impact of Obesity on Vaginal Myomectomy Outcomes in the Management of Uterine Leiomyomas
Gynecologic and Obstetric Investigation · 2026
DOI: 10.1159/000550970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2026. Verfasst von Turan Sahin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Sancaktepe Training and Research Hospital, Istanbul, Turkey, dr.turanshn@gmail.com. Hauptthemen laut MEDLINE: Leiomyoma, Obesity, Uterine Myomectomy, Uterine Neoplasms.
Abstract (Originalsprache)
Introduction
To evaluate the effect of obesity on vaginal myomectomy (VM) results.
Methods
Patients who underwent VM for uterine leiomyomas were enrolled in the study. Demographic characteristics of patients, leiomyoma-related properties, and operative and postoperative parameters were retrieved from medical records. The study population was divided into two groups according to BMI: patients with BMI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Sancaktepe Training and Research Hospital, Istanbul, Turkey, dr.turanshn@gmail.com.
- Department of Gynecology and Obstetrics, EA Sahin Clinic, Istanbul, Turkey.
- Department of Gynecology and Obstetrics, Sahin Clinic, Istanbul, Turkey.
Zitieren
APA
Sahin, T., Sahin, E. A., & Sahin, H. (2026). Impact of Obesity on Vaginal Myomectomy Outcomes in the Management of Uterine Leiomyomas. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000550970
Vancouver
Sahin T, Sahin EA, Sahin H. Impact of Obesity on Vaginal Myomectomy Outcomes in the Management of Uterine Leiomyomas. Gynecologic and Obstetric Investigation. 2026. doi:10.1159/000550970
BibTeX
@article{Sahin2026,
author = {Sahin, Turan and Sahin, Eda Adeviye and Sahin, Hanifi},
title = {Impact of Obesity on Vaginal Myomectomy Outcomes in the Management of Uterine Leiomyomas},
journal = {Gynecologic and Obstetric Investigation},
year = {2026},
doi = {10.1159/000550970}
}
EUVIMED